Lupus

Immunology·MeSH: Lupus Erythematosus, Systemic
122 drugs in development·61 companies·3 clinical trials

Drug Pipeline by Phase

Phase 3(25)
DrugCompany
ANX009Annexon, Inc. (ANNX)
AZD0120ASTRAZENECA PLC (AZN)
biib059BIOGEN INC. (BIIB)
cenerimodInnovation Pharmaceuticals Inc. (IPIX)
CenerimodCrinetics Pharmaceuticals, Inc. (CRNX)
chemotherapy agentsTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
dapirolizumab pegolGT Biopharma, Inc. (GTBP)
dapirolizumab pegolPOINT Biopharma Global Inc. (PNT)
dapirolizumab pegolBIOGEN INC. (BIIB)
Dapirolizumab PegolNEKTAR THERAPEUTICS (NKTR)
descartes-08Cartesian Therapeutics, Inc. (RNAC)
dnth212Dianthus Therapeutics, Inc. /DE/ (DNTH)
dzpPOINT Biopharma Global Inc. (PNT)
dzpGT Biopharma, Inc. (GTBP)
ESK-001ALUMIS INC. (ALMS)
FludarabineBRISTOL MYERS SQUIBB CO (BMY)
IanalumabNovartis AG (NVS)
ianalumab s.c. q12wNovartis AG (NVS)
ianalumab s.c. q12wNovartis AG (NVS)
ianalumab s.c. q4wNovartis AG (NVS)
Medi-546ASTRAZENECA PLC (AZN)
sar448501Sanofi (SNYNF)
TocilizumabBRISTOL MYERS SQUIBB CO (BMY)
UCAR-T cellsFilana Therapeutics Inc. (FLNA)
voclosporinAurinia Pharmaceuticals Inc. (AUPH)
Phase 2(34)
DrugCompany
afimetoranBRISTOL MYERS SQUIBB CO (BMY)
AKB-097Akebia Therapeutics, Inc. (AKBA)
alpn-101ALPINE IMMUNE SCIENCES, INC. (ALPN)
anifrolumabValneva SE (VALN)
AtaciceptVera Therapeutics, Inc. (VERA)
AUCATZYL/obe-celAutolus Therapeutics plc (AUTL)
AZD5492ASTRAZENECA PLC (AZN)
belimumab 10mg/kgGSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
cc-97540Juno Therapeutics, Inc. (JUNO)
CC-97540BRISTOL MYERS SQUIBB CO (BMY)
cd19CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
cfz533Novartis AG (NVS)
daxdilimabAMGEN INC (AMGN)
glpg3667Galapagos NV (GLPG)
GLPG3667Galapagos NV (GLPG)
iberdomideCELGENE CORP /DE/ (CELG)
imvotamabIGM Biosciences, Inc. (IGMS)
inebilizumabAMGEN INC (AMGN)
mb-cart19.1CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
MK-1045Merck & Co., Inc. (MRK)
obecabtagene autoleucelAutolus Therapeutics plc (AUTL)
prv-3279Sanofi (SNY)
prv-3279Sanofi (SNYNF)
prv-3279PROVENTION BIO, INC. (PBI)
PRV-3279MACROGENICS INC (MGNX)
ra101495 scRA PHARMACEUTICALS, INC. (RARX)
rapcabtagene autoleucelNovartis AG (NVS)
rese-celCabaletta Bio, Inc. (CABA)
sar441344 ivSanofi (SNY)
sar441344 ivSanofi (SNYNF)
sar441344 scSanofi (SNYNF)
sar441344 scSanofi (SNY)
sar443122Sanofi (SNY)
zetomipzomibKezar Life Sciences, Inc. (KZR)
Phase 1(27)
DrugCompany
abbv-519AbbVie Inc. (ABBV)
ADI-001Adicet Bio, Inc. (ACET)
ALLO-329Allogene Therapeutics, Inc. (ALLO)
AZD0120Merus N.V. (MRUS)
blinatumomabAMGEN INC (AMGN)
cenerimodViatris Inc (VTRS)
cnty-101Century Therapeutics, Inc. (IPSC)
cnty-308Century Therapeutics, Inc. (IPSC)
cnty-341Century Therapeutics, Inc. (IPSC)
cnty-813Century Therapeutics, Inc. (IPSC)
CTX112CRISPR Therapeutics AG (CRSP)
fludarabineCELLULAR BIOMEDICINE GROUP, INC. (CMBG)
il-2Century Therapeutics, Inc. (IPSC)
itolizumab [bmab 600]Equillium, Inc. (EQ)
LitifilimabBIOGEN INC. (BIIB)
LP659Longboard Pharmaceuticals, Inc. (LBPH)
LUCAR-G79D T cellsLegend Biotech Corp (LEGN)
lymphodepleting chemotherapyCentury Therapeutics, Inc. (IPSC)
pit565Novartis AG (NVS)
pit565Novartis AG (NVS)
prula-celAdicet Bio, Inc. (ACET)
pt101Pandion Therapeutics, Inc. (PAND)
rese-cel (resecabtagene autoleucel)Cabaletta Bio, Inc. (CABA)
sar448501Sanofi (SNY)
sc291Sana Biotechnology, Inc. (SANA)
vonsetamigREGENERON PHARMACEUTICALS, INC. (REGN)
zamtocabtagene autoleucelCELLULAR BIOMEDICINE GROUP, INC. (CMBG)

Compare drugs

ANX009 vs AZD0120ANX009 vs biib059ANX009 vs cenerimod

Frequently asked questions

How many drugs are in development for Lupus?

BioSniper tracks 122 drugs in development for Lupus across 61 companies.

How many clinical trials target Lupus?

There are 3 clinical trials targeting Lupus tracked by BioSniper.

Deep-dive into Lupus

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis